Landscapes / Companies
PureTech not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 4 in all
Trials
2 active
9 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | Nov 2029Phase 3 trial completes | |||
| Next date | Nov 2029 · Phase 3 trial completes | ||||
| Also tested for | Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF) | ||||
| Open drug page | |||||
About
- No active trial
- LYT-200, LYT-300, Nintedanib
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021